Implementing contingency management for stimulant use in opioid treatment programs: protocol of a type III hybrid effectiveness-stepped-wedge trial.
Sara J Becker, Kira DiClemente-Bosco, Kelli Scott...
https://pubmed.ncbi.nlm.nih.gov/37705093/Actively Recruiting
Led by Northwestern University · Updated on 2026-05-01
76
Participants Needed
9
Research Sites
17 weeks
Total Duration
Researchers are evaluating a multi-level approach called the Science of Service Laboratory to increase the use of contingency management for stimulant use among people receiving medication for opioid use disorder. This study focuses on public sector addiction specialty treatment programs and aims to improve both how contingency management is implemented and patient outcomes. The trial addresses the gap in using contingency management, an evidence-based intervention for stimulant addiction, within opioid treatment programs. The study uses a stepped wedge design where addiction programs are randomized in cohorts to receive the Science of Service Laboratory strategy. This approach includes didactic training with workshops and coaching calls, performance feedback through practice sessions and electronic medical record data, and external facilitation with monthly calls. Programs start with usual care and then transition to the implementation strategy, allowing comparison before and after the intervention. Participants include opioid treatment program counselors providing psychosocial support and patients newly started on medication for opioid use disorder who also use stimulants. Data collected include de-identified electronic medical records on contingency management delivery and patient outcomes, alongside staff reports on implementation factors. Primary outcomes focus on changes in the percentage of patients receiving contingency management and counselors delivering it over 10 months. Secondary outcomes include stimulant abstinence measured by toxicology screens and the number of contingency management sessions.
CONDITIONS
Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
S
Sara Becker
K
Kira DiClemente-Bosco
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Northwestern University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | SSL implementation strategy | No intervention period | Established CM programs (context) |
|---|---|---|---|
| What it is | A multicomponent implementation strategy combining training, feedback, and facilitation to support delivery of contingency management in opioid treatment programs. | Usual practice period without specific implementation support for contingency management. | Contingency management is an evidence-based behavioral intervention widely recognized as the standard of care for stimulant use disorder. |
| Role in trial | Implementation support condition aiming to increase use of contingency management by counselors. | Control or usual practice period without additional support for CM delivery. | Represents current clinical practice in behavioral treatment for stimulant use, outside trial. |
| Primary use | To increase counselor delivery of contingency management in treatment programs. | Continuation of existing practices without structured implementation support. | Providing contingency management interventions directly to patients with stimulant use. |
| How it is given or performed | Counselors receive didactic training, monthly coaching and facilitation calls, and performance feedback to support CM delivery. | No structured training or facilitation provided for CM frequency during this period. | Clinically delivered contingency management—providing incentives for abstinence or treatment behaviors as part of routine care. |
| Evidence status | Effectiveness of SSL in promoting CM delivery is under evaluation; trial results not yet available. | No improvement expected beyond existing CM delivery levels. | Contingency management is highly effective in improving abstinence and engagement for stimulant use disorder. |
| Important limitations | Implementation outcomes may vary across programs and staff; generalizability beyond study settings may be limited. | Does not address barriers to CM adoption; may reflect underuse despite evidence base. | Despite strong evidence, CM is underutilized in community settings due to funding, training, and policy barriers. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) to confirm eligibility
Duration - 10 months
Participants receive the Science of Service Laboratory implementation strategy, which includes didactic training, performance feedback, and facilitation to support contingency management for stimulant use.
Monthly coaching and facilitation calls, plus ongoing practice sessions
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sara J Becker, Kira DiClemente-Bosco, Kelli Scott...
https://pubmed.ncbi.nlm.nih.gov/37705093/Northwestern University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor